Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2012 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Provides Corporate Update

WINNIPEG, MANITOBA--(Marketwire - Feb. 21, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
January 17, 2012 10:27 ET | Source: Kane Biotech Inc.

Kane Biotech Renews Investor Relations Agreement With Pure Advertising and Marketing for 2012

WINNIPEG, MANITOBA--(Marketwire - Jan. 17, 2012) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
December 15, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Submits Supplemental Data on KBI Disinfectant to Health Canada

WINNIPEG, MANITOBA--(Marketwire - Dec. 15, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
December 12, 2011 11:21 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Appointment of Mark Matthewson as New CFO

WINNIPEG, MANITOBA--(Marketwire - Dec. 12, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and...
December 08, 2011 10:12 ET | Source: Kane Biotech Inc.

Kane Biotech Issued New Patents in China and USA

WINNIPEG, MANITOBA--(Marketwire - Dec. 8, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
November 11, 2011 11:00 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Extension of Term of Warrants

WINNIPEG, MANITOBA--(Marketwire - Nov. 11, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company"), a biotechnology company engaged in the development of products that prevent and...
November 09, 2011 13:42 ET | Source: Kane Biotech Inc.

Kane Biotech Inc.: FDA Provides Feedback and Roadmap for DispersinB(R) Development

WINNIPEG, MANITOBA--(Marketwire - Nov. 9, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
October 12, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Receives Approval from Health Canada for Hard Surface Disinfectant

WINNIPEG, MANITOBA--(Marketwire - Oct. 12, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
August 30, 2011 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Files New Patent on Bone Tissue Regeneration Invention

WINNIPEG, MANITOBA--(Marketwire - Aug. 30, 2011) - Highlights: Invention and patenting of a new bone tissue regenerating technology ...
July 26, 2011 08:43 ET | Source: Kane Biotech Inc.

DispersinB(R) Effective Against Superbug MRSA

WINNIPEG, MANITOBA--(Marketwire - July 26, 2011) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...